Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers

Summary: RNA-binding proteins (RBPs) regulate the expression of thousands of transcripts, and some are reported to be involved in human tumorigenesis. However, little is known about the dysregulation of RBPs at the genomic level in human cancers. Here, we conducted comprehensive analyses for express...

Full description

Bibliographic Details
Main Authors: Ze-Lin Wang, Bin Li, Yu-Xia Luo, Qiao Lin, Shu-Rong Liu, Xiao-Qin Zhang, Hui Zhou, Jian-Hua Yang, Liang-Hu Qu
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124717318442
_version_ 1818563313317969920
author Ze-Lin Wang
Bin Li
Yu-Xia Luo
Qiao Lin
Shu-Rong Liu
Xiao-Qin Zhang
Hui Zhou
Jian-Hua Yang
Liang-Hu Qu
author_facet Ze-Lin Wang
Bin Li
Yu-Xia Luo
Qiao Lin
Shu-Rong Liu
Xiao-Qin Zhang
Hui Zhou
Jian-Hua Yang
Liang-Hu Qu
author_sort Ze-Lin Wang
collection DOAJ
description Summary: RNA-binding proteins (RBPs) regulate the expression of thousands of transcripts, and some are reported to be involved in human tumorigenesis. However, little is known about the dysregulation of RBPs at the genomic level in human cancers. Here, we conducted comprehensive analyses for expression, somatic copy number alteration (SCNA), and mutation profiles of 1,542 RBPs in ∼7,000 clinical specimens across 15 cancer types. We identified markedly dysregulated RBPs and found that downregulation was a predominant pattern in cancer. Combined with recurrent SCNA data, we identified 76 RBPs as potential drivers. We also discovered a set of 139 RBPs that were significantly mutated in cancers. We confirmed the oncogenic property of six RBPs in colorectal and liver cancer cell lines by using in vitro functional experiments. Our study highlights the potential roles of RBPs in carcinogenesis and lays the groundwork to better understand the functions and mechanisms of RBPs in cancer. : Wang et al. characterize transcriptional and genomic alterations in the landscape of RNA-binding proteins (RBPs) in ∼7,000 clinical samples across 15 human cancer types and experimentally validate the effects of several cancer-related RBPs on cell viability. Keywords: RNA-binding proteins, dysregulation, somatic copy number alterations, mutation profile, cancer driver
first_indexed 2024-12-14T01:15:02Z
format Article
id doaj.art-e6e8d395d2344266939dc7fb227d30ce
institution Directory Open Access Journal
issn 2211-1247
language English
last_indexed 2024-12-14T01:15:02Z
publishDate 2018-01-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj.art-e6e8d395d2344266939dc7fb227d30ce2022-12-21T23:22:38ZengElsevierCell Reports2211-12472018-01-01221286298Comprehensive Genomic Characterization of RNA-Binding Proteins across Human CancersZe-Lin Wang0Bin Li1Yu-Xia Luo2Qiao Lin3Shu-Rong Liu4Xiao-Qin Zhang5Hui Zhou6Jian-Hua Yang7Liang-Hu Qu8Key Laboratory of Gene Engineering of the Ministry of Education, Sun Yat-sen University, Guangzhou 510275, China; State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou 510275, ChinaKey Laboratory of Gene Engineering of the Ministry of Education, Sun Yat-sen University, Guangzhou 510275, China; State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou 510275, ChinaKey Laboratory of Gene Engineering of the Ministry of Education, Sun Yat-sen University, Guangzhou 510275, China; State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou 510275, ChinaKey Laboratory of Gene Engineering of the Ministry of Education, Sun Yat-sen University, Guangzhou 510275, China; State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou 510275, ChinaKey Laboratory of Gene Engineering of the Ministry of Education, Sun Yat-sen University, Guangzhou 510275, China; State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou 510275, ChinaSchool of Medicine, South China University of Technology, Guangzhou 510275, China; Department of Surgery, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong 999077, ChinaKey Laboratory of Gene Engineering of the Ministry of Education, Sun Yat-sen University, Guangzhou 510275, China; State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou 510275, ChinaKey Laboratory of Gene Engineering of the Ministry of Education, Sun Yat-sen University, Guangzhou 510275, China; State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou 510275, China; Corresponding authorKey Laboratory of Gene Engineering of the Ministry of Education, Sun Yat-sen University, Guangzhou 510275, China; State Key Laboratory for Biocontrol, Sun Yat-sen University, Guangzhou 510275, China; Corresponding authorSummary: RNA-binding proteins (RBPs) regulate the expression of thousands of transcripts, and some are reported to be involved in human tumorigenesis. However, little is known about the dysregulation of RBPs at the genomic level in human cancers. Here, we conducted comprehensive analyses for expression, somatic copy number alteration (SCNA), and mutation profiles of 1,542 RBPs in ∼7,000 clinical specimens across 15 cancer types. We identified markedly dysregulated RBPs and found that downregulation was a predominant pattern in cancer. Combined with recurrent SCNA data, we identified 76 RBPs as potential drivers. We also discovered a set of 139 RBPs that were significantly mutated in cancers. We confirmed the oncogenic property of six RBPs in colorectal and liver cancer cell lines by using in vitro functional experiments. Our study highlights the potential roles of RBPs in carcinogenesis and lays the groundwork to better understand the functions and mechanisms of RBPs in cancer. : Wang et al. characterize transcriptional and genomic alterations in the landscape of RNA-binding proteins (RBPs) in ∼7,000 clinical samples across 15 human cancer types and experimentally validate the effects of several cancer-related RBPs on cell viability. Keywords: RNA-binding proteins, dysregulation, somatic copy number alterations, mutation profile, cancer driverhttp://www.sciencedirect.com/science/article/pii/S2211124717318442
spellingShingle Ze-Lin Wang
Bin Li
Yu-Xia Luo
Qiao Lin
Shu-Rong Liu
Xiao-Qin Zhang
Hui Zhou
Jian-Hua Yang
Liang-Hu Qu
Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers
Cell Reports
title Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers
title_full Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers
title_fullStr Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers
title_full_unstemmed Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers
title_short Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers
title_sort comprehensive genomic characterization of rna binding proteins across human cancers
url http://www.sciencedirect.com/science/article/pii/S2211124717318442
work_keys_str_mv AT zelinwang comprehensivegenomiccharacterizationofrnabindingproteinsacrosshumancancers
AT binli comprehensivegenomiccharacterizationofrnabindingproteinsacrosshumancancers
AT yuxialuo comprehensivegenomiccharacterizationofrnabindingproteinsacrosshumancancers
AT qiaolin comprehensivegenomiccharacterizationofrnabindingproteinsacrosshumancancers
AT shurongliu comprehensivegenomiccharacterizationofrnabindingproteinsacrosshumancancers
AT xiaoqinzhang comprehensivegenomiccharacterizationofrnabindingproteinsacrosshumancancers
AT huizhou comprehensivegenomiccharacterizationofrnabindingproteinsacrosshumancancers
AT jianhuayang comprehensivegenomiccharacterizationofrnabindingproteinsacrosshumancancers
AT lianghuqu comprehensivegenomiccharacterizationofrnabindingproteinsacrosshumancancers